SFRS8 Polyclonal antibody

SFRS8 Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (1)

Applications

WB, IHC, IF/ICC, ELISA

Conjugate

Unconjugated

Cat no : 24705-1-AP

Synonyms

SFRS8, SWAP



Tested Applications

Positive WB detected inJurkat cells, HeLa cells
Positive IF/ICC detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:4000
Immunofluorescence (IF)/ICCIF/ICC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 24705-1-AP is SFRS8 Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SFRS8 fusion protein Ag19762
Full Name splicing factor, arginine/serine-rich 8 (suppressor-of-white-apricot homolog, Drosophila)
Calculated Molecular Weight 951 aa, 105 kDa
Observed Molecular Weight 130-150 kDa
GenBank Accession NumberBC136678
Gene Symbol SFRS8
Gene ID (NCBI) 6433
RRIDAB_2879682
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

SFRS8, also named as SFSWAP and SWAP, is splicing regulator. It regulates the splicing of fibronectin and CD45 genes. SFRS8 represses the splicing of MAPT/Tau exon 10. This antibody detects 130-150 kDa SFRS8 protein.

Protocols

Product Specific Protocols
WB protocol for SFRS8 antibody 24705-1-APDownload protocol
IF protocol for SFRS8 antibody 24705-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,mouseWB,IHC

Clin Transl Med

Splicing factor arginine/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication.

Authors - Yuanjiao Zhang